Open Book Extracts (OBX), a cannabinoid product manufacturer, has inked a term sheet to acquire Nucl3o, a processor of high-purity cannabinoid isolates, Benzinga Cannabis has learned exclusively.

Austin-based ketamine therapy provider Mindbloom is launching its Mastermind Series, the first-of-its-kind, expert-led psychedelic therapy program for overcoming severe mental and emotional health challenges.

In an exclusive interview with Benzinga, BDSA analyst Brendan Mitchel-Chesebro provided a detailed analysis of Ohio's emerging recreational cannabis market.

"Much like the plant, the future of cannabis is female. I absolutely see major growth over the next 2-4 years, albeit slowly in terms of cannabis funding.

Beckley Retreats, a science-backed psilocybin retreats and holistic wellbeing company, is officially launching its Signature Program for Personal Discovery and Transformation, “an 11-week curriculum of preparation and integration support to help guests achieve the most significant benefit from their six-day psilocybin retreats” in Jamaica and the Ne

Legendary boxing champion Mike Tyson and Carma HoldCo Inc. announced on Tuesday that they will debut of their Tyson 2.0 cannabis brand in New York via a partnership with Hudson Cannabis.

Clearmind Medicine Inc (NASDAQ: CMND) has released results from its pre-clinical trial of the combination therapy.